Viewing StudyNCT00066326



Ignite Creation Date: 2024-05-05 @ 11:30 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00066326
Status: COMPLETED
Last Update Posted: 2013-04-05
First Post: 2003-08-06

Brief Title: Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
Sponsor:
Organization: Barbara Ann Karmanos Cancer Institute